title: Rituximab for primary angiitis of the central nervous system: report of 2 patients from the French COVAC cohort and review of the literature.
authors.affiliation: Department of Internal Medicine, Centre Hospitalier Universitaire de la côte de Nacre, Caen; and Division of Internal Medicine, Hôpital Cochin, AP-HP, Université Paris-Descartes, Paris;
authors.forename: Hubert
authors.initials: H
authors.lastname: De Boysson
authors.forename: Caroline
authors.initials: C
authors.lastname: Arquizan
authors.forename: Loic
authors.initials: L
authors.lastname: Guillevin
authors.forename: Christian
authors.initials: C
authors.lastname: Pagnoux
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002560:Cerebrovascular Circulation; D005260:Female; D005602:France; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D020293:Vasculitis, Central Nervous System / Q000188:drug therapy* / Q000473:pathology*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab